1Pefi A, Bonaccorsi L, Muratofi M, et al. Uteroglobin reverts the transformed phenotype in the endometrial carcinoma cell line HEC - 1 A by discrupting the metabolic pathways generating platelet - activating factor[J]. Int J Cancer, 2000,88(4) : 524 -534.
4Pattabiraman N, Matthews JH, Ward KB, et al. Crystal structure analysis of recombinant human uteroglobin and molecular of ligand binding[ J ]. Ann N Y Acad Sci, 2000, 923 : 113 - 127.
5Chowdhury B, Mantile -Selvaggi G, Miele L, et al. Lys43 and Asp46 in alpha - helix 3 of uteroglobin are essential for its phospholipase A2 inhibitory activity [ J ]. Biochem Biophys Res Commun, 2002, 295(4): 877 -883.
6Stohr H, Marquardt A, White K, et al. cDNA cloning and genomic structure of a novel gene ( cl 1 or f 9) localized to chromosome 11 q12 - q13.1 which encodes a highly conserved, potential membrane - associated protein[ J ]. Cytogenet Cell Genet, 2000,88 (3 - 4) :211.
7Patiemo SR, Manjak MJ, Fernandez PM, et al. Uteroglobin: a potential novel tumor suppressor and molecular therapeutic for prostate cancer[J]. Clin Prostate Cancer, 2002,1 (2) : 118 - 124.
8Kundu GC, Mandal AK, Zhang Z, et al. Uteroglobin (UG) suppresses extracellular matrix invasion by normal and cancer cells that express the high affinity UG - binding proteins [ J ]. J Biol Chem, 1998, 273(35) : 22819 -22824.
9Szabo E,et al. Overexpression of CC10 modifies neoplastic potential in lung cancer cells[J]. Cell Growth Differ, 1998,9(6) : 475 -485.
10Shijubo N, Kawabata Z, Sato N, et al. Clinical aspects of Clara cell 10 - kDa protein/uteroglobin ( secretoglobin 1A1 ) [ J]. Curt Pharm Des, 2003,9(14) : 1139 - 1149.
二级参考文献30
1Mukherjee AB, Kundu C,C, Mantile-Selvaggi G, et al. Cell Mol Life Sci,1999;55:771 - 87.
